183 related articles for article (PubMed ID: 7574514)
1. Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide.
Speirs RJ; Welch JT; Cynamon MH
Antimicrob Agents Chemother; 1995 Jun; 39(6):1269-71. PubMed ID: 7574514
[TBL] [Abstract][Full Text] [Related]
2. Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages.
Pires D; Valente E; Simões MF; Carmo N; Testa B; Constantino L; Anes E
Antimicrob Agents Chemother; 2015 Dec; 59(12):7693-9. PubMed ID: 26438493
[TBL] [Abstract][Full Text] [Related]
3. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide.
Zhang Y; Scorpio A; Nikaido H; Sun Z
J Bacteriol; 1999 Apr; 181(7):2044-9. PubMed ID: 10094680
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity.
Raynaud C; Lanéelle MA; Senaratne RH; Draper P; Lanéelle G; Daffé M
Microbiology (Reading); 1999 Jun; 145 ( Pt 6)():1359-1367. PubMed ID: 10411262
[TBL] [Abstract][Full Text] [Related]
5. Antimycobacterial activity of a series of pyrazinoic acid esters.
Cynamon MH; Klemens SP; Chou TS; Gimi RH; Welch JT
J Med Chem; 1992 Apr; 35(7):1212-5. PubMed ID: 1560435
[TBL] [Abstract][Full Text] [Related]
6. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide.
Sun Z; Zhang Y
Antimicrob Agents Chemother; 1999 Mar; 43(3):537-42. PubMed ID: 10049264
[TBL] [Abstract][Full Text] [Related]
7. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.
Zimic M; Fuentes P; Gilman RH; Gutiérrez AH; Kirwan D; Sheen P
Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792
[TBL] [Abstract][Full Text] [Related]
8. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
[TBL] [Abstract][Full Text] [Related]
9. Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamide.
Dillon NA; Peterson ND; Rosen BC; Baughn AD
Antimicrob Agents Chemother; 2014 Dec; 58(12):7258-63. PubMed ID: 25246400
[TBL] [Abstract][Full Text] [Related]
10. Pyrazinoic Acid Inhibits a Bifunctional Enzyme in Mycobacterium tuberculosis.
Njire M; Wang N; Wang B; Tan Y; Cai X; Liu Y; Mugweru J; Guo J; Hameed HMA; Tan S; Liu J; Yew WW; Nuermberger E; Lamichhane G; Liu J; Zhang T
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438933
[TBL] [Abstract][Full Text] [Related]
11. Metallochaperones Are Needed for Mycobacterium tuberculosis and Escherichia coli Nicotinamidase-Pyrazinamidase Activity.
Sheen P; Monsalve A; Campos J; Huerta R; Antiparra R; Arteaga H; Duran P; Bueno C; Kirwan DE; Gilman RH; Zimic M
J Bacteriol; 2020 Jan; 202(2):. PubMed ID: 31636108
[No Abstract] [Full Text] [Related]
12. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y
Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313
[TBL] [Abstract][Full Text] [Related]
13. Rapid detection of pyrazinamide-resistant Mycobacterium tuberculosis by a PCR-based in vitro system.
Suzuki Y; Suzuki A; Tamaru A; Katsukawa C; Oda H
J Clin Microbiol; 2002 Feb; 40(2):501-7. PubMed ID: 11825963
[TBL] [Abstract][Full Text] [Related]
14. Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli.
Zimhony O; Vilchèze C; Arai M; Welch JT; Jacobs WR
Antimicrob Agents Chemother; 2007 Feb; 51(2):752-4. PubMed ID: 17101678
[TBL] [Abstract][Full Text] [Related]
15. In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.
Gopal P; Tasneen R; Yee M; Lanoix JP; Sarathy J; Rasic G; Li L; Dartois V; Nuermberger E; Dick T
ACS Infect Dis; 2017 Jul; 3(7):492-501. PubMed ID: 28271875
[TBL] [Abstract][Full Text] [Related]
16. QSAR modeling of a set of pyrazinoate esters as antituberculosis prodrugs.
Fernandes JP; Pasqualoto KF; Felli VM; Ferreira EI; Brandt CA
Arch Pharm (Weinheim); 2010 Feb; 343(2):91-7. PubMed ID: 20099263
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling Environmental pH and Intrabacterial Acidification from Pyrazinamide Susceptibility in Mycobacterium tuberculosis.
Peterson ND; Rosen BC; Dillon NA; Baughn AD
Antimicrob Agents Chemother; 2015 Dec; 59(12):7320-6. PubMed ID: 26369957
[TBL] [Abstract][Full Text] [Related]
18. Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis.
Simões MF; Valente E; Gómez MJ; Anes E; Constantino L
Eur J Pharm Sci; 2009 Jun; 37(3-4):257-63. PubMed ID: 19491013
[TBL] [Abstract][Full Text] [Related]
19. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362
[TBL] [Abstract][Full Text] [Related]
20. Non-
Werngren J; Alm E; Mansjö M
J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]